Skip to content

A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-503046-50-00
Acronym
1479-0011
Enrollment
16
Registered
2023-07-19
Start date
2023-09-11
Completion date
2023-12-08
Last updated
2023-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026